These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 7824731

  • 1. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL, Mitchell DS, Ungar DR, Prakash D, Dole MG, Castle VP, Hernandez RJ, Koeppe RA, Hutchinson RJ.
    Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
    [Abstract] [Full Text] [Related]

  • 2. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
    Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC.
    Radiology; 1996 Jun; 199(3):743-50. PubMed ID: 8637999
    [Abstract] [Full Text] [Related]

  • 3. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Martin WH, Delbeke D, Patton JA, Sandler MP.
    Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
    [Abstract] [Full Text] [Related]

  • 4. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
    Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitzsche E.
    J Comput Assist Tomogr; 1993 Jan; 17(4):582-9. PubMed ID: 8331230
    [Abstract] [Full Text] [Related]

  • 5. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS, Francis IR, Kaminski MS, Wahl RL.
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [Abstract] [Full Text] [Related]

  • 6. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ, Cotton L, Ackermann RJ, Minn H, Ficaro EP, Shreve PD, Wahl RL.
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [Abstract] [Full Text] [Related]

  • 7. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans.
    Zasadny KR, Kison PV, Quint LE, Wahl RL.
    Radiology; 1996 Dec; 201(3):873-6. PubMed ID: 8939245
    [Abstract] [Full Text] [Related]

  • 8. PET FDG studies of Wilms tumors.
    Shulkin BL, Chang E, Strouse PJ, Bloom DA, Hutchinson RJ.
    J Pediatr Hematol Oncol; 1997 Dec; 19(4):334-8. PubMed ID: 9256833
    [Abstract] [Full Text] [Related]

  • 9. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Dehdashti F, Siegel BA, Griffeth LK, Fusselman MJ, Trask DD, McGuire AH, McGuire DJ.
    Radiology; 1996 Jul; 200(1):243-7. PubMed ID: 8657920
    [Abstract] [Full Text] [Related]

  • 10. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
    Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC.
    J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337
    [Abstract] [Full Text] [Related]

  • 11. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS, Francis IR, Zasadny KR, Wahl RL.
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [Abstract] [Full Text] [Related]

  • 12. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
    Lapela M, Grénman R, Kurki T, Joensuu H, Leskinen S, Lindholm P, Haaparanta M, Ruotsalainen U, Minn H.
    Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
    [Abstract] [Full Text] [Related]

  • 13. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
    Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC.
    Radiology; 1999 Jul; 212(1):35-41. PubMed ID: 10405717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
    Dehdashti F, Mortimer JE, Siegel BA, Griffeth LK, Bonasera TJ, Fusselman MJ, Detert DD, Cutler PD, Katzenellenbogen JA, Welch MJ.
    J Nucl Med; 1995 Oct; 36(10):1766-74. PubMed ID: 7562040
    [Abstract] [Full Text] [Related]

  • 16. [Cancer screening with whole-body FDG PET].
    Yasuda S, Ide M, Takagi S, Shohtsu A.
    Kaku Igaku; 1996 Oct; 33(10):1065-71. PubMed ID: 8952258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 19. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
    Minn H, Zasadny KR, Quint LE, Wahl RL.
    Radiology; 1995 Jul; 196(1):167-73. PubMed ID: 7784562
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.